Israel Englander’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Israel Englander’s Portfolio AYLA Stock Details AYLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,913	Closed	-$15K	–	7379
2022 Q3	$15K	Sell	14,913 -15,657	-51%	-$21.1K	﹤0.01%	6553
2022 Q2	$33K	Sell	30,570 -41,947	-58%	-$95.8K	﹤0.01%	6334
2022 Q1	$289K	Buy	+72,517	New	+$377K	﹤0.01%	5582
2021 Q2	–	Sell	-12,407	Closed	-$135K	–	7337
2021 Q1	$135K	Sell	12,407 -8,695	-41%	-$124K	﹤0.01%	5619
2020 Q4	$240K	Sell	21,102 -15,325	-42%	-$177K	﹤0.01%	4704
2020 Q3	$429	Sell	36,427 -25,359	-41%	-$297K	﹤0.01%	3656
2020 Q2	$620K	Buy	+61,786	New	+$859K	﹤0.01%	3275

Other funds holding AYLA

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

APP

Avantax Planning Partners Dubuque, Iowa $4.02B AUM 20% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Israel Englander's AYLA Position: Q4 2022 in Review

Israel Englander sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q4 2022, closing a stake of 14,913 shares — an estimated $15K sold.

Israel Englander first reported a position in AYLA in Q2 2020 and held it in 7 quarters. The position peaked at $620K in Q2 2020. 11 funds tracked by Wall St. Rank hold AYLA as of Q4 2022.

Israel Englander reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Israel Englander sold 14,913 Ayala Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $15K.
Israel Englander first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 7 quarters.
Israel Englander's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $620K in Q2 2020.
11 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.